ENDURANT CAPITAL MANAGEMENT LP – Sutro Biopharma, Inc. Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$1.48M
portfolio value
ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:
+6.53%
quarter
Sutro Biopharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -25.40% | -90.78K shares | -382K | $5.55 | 266.67K |
| Q2 2022 | share | Increase | +20.56% | 60.95K shares | -575K | $5.21 | 357.46K |
| Q1 2022 | share | Increase | +165.21% | 184.70K shares | 773K | $8.22 | 296.50K |
| Q4 2021 | share | Increase | 0.00% | 111.80K shares | 1.66M | $15.06 | 111.80K |
| Q1 2021 | share | Decrease | -100.00% | -172.04K shares | -3.73M | $22.76 | 0 |
| Q4 2020 | share | Decrease | -62.77% | -290.12K shares | -910K | $21.71 | 172.04K |
| Q3 2020 | share | Increase | +196.25% | 306.16K shares | 3.43M | $10.05 | 462.17K |
| Q2 2020 | share | Increase | 0.00% | 156.00K shares | 1.21M | $7.76 | 156.00K |
| Q1 2020 | share | Decrease | -100.00% | -32.66K shares | -359K | $10.2 | 0 |
| Q4 2019 | share | Increase | 0.00% | 32.66K shares | 359K | $11 | 32.66K |